prostaglandin E1
Jump to navigation
Jump to search
Indications
- maintenance of patent ductus arteriosus in neonatal cyanotic congenital heart disease
- pulmonary hypertension[3]
- peripheral vascular disease
More general terms
More specific terms
Additional terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996 pg
- ↑ Merck Index, I2th ed, Merck & Co, Rahway NJ, 1996 # 8062
- ↑ Jump up to: 3.0 3.1 3.2 Deprecated Reference